Apitope Plans 2013 Financing to Advance Autoimmune Drugs
By Nuala Moran
Tuesday, November 27, 2012
LONDON Apitope Ltd. is busy drawing up the business plan for a double-digit financing round to take its next two projects through Phase I development after triggering a key clinical milestone in its lead multiple sclerosis program.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.